Approved PLCO Projects
Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.
Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
---|---|---|---|---|---|
Food and Colorectal Cancer | Duj Singh | West China Hospital | PLCO | Jan 12, 2023 | PLCO-1144 |
A Deep Learning Algorithm using the PLCO data to estimate cancer risk from multiple cancers | Ping Hu | National Cancer Institute | PLCO | Jan 12, 2023 | PLCO-1142 |
Research gaps in PSA tests and race-specific risk factors | Anwar Ahmed | Uniformed Services University | PLCO | Jan 11, 2023 | PLCO-1141 |
Analysing non-clinical attributes of Male Breast Cancer using Machine Learning | Vaidehi Gajera | Western Sydney University | PLCO | Jan 11, 2023 | PLCO-1143 |
Diabetes risk reduction diet and the risk of head and neck cancer: a large prospective cohort study | Ling Xiang | The Second Affiliated Hospital of Chongqing Medical University | PLCO | Jan 5, 2023 | PLCO-1140 |
Diabetes risk reduction diet and the risk of bladder cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial | Yuanhao Chen | Department of Urology,Beijing Chaoyang Hospital Affiliated To Capital Medical University | PLCO | Jan 3, 2023 | PLCO-1138 |
Prostate Cancer Clinical Outcomes | K.C Balaji | UF Health Jacksonville | PLCO | Jan 3, 2023 | PLCO-1139 |
The association between dietary approaches to stop hypertension eating pattern and the risk of lung cancer in the PLCO Cancer Screening Trial | Linglong Peng | The Second Affiliated Hospital of Chongqing Medical University | PLCO | Dec 29, 2022 | PLCO-1137 |
Spatial and socioeconomic disparity in the colorectal cancer screening rate | Yoshito Nishimura | University of Hawaii | PLCO | Dec 27, 2022 | PLCO-1135 |
Optimizing combination of chemotherapy and checkpoint inhibitors of oncology treatment by offline deep reinforcement learning | Yao Yao | City University of Hong Kong | PLCO | Dec 27, 2022 | PLCO-1133 |
The Sulfur Microbial Diet Is Associated with Increased Risk of Esophageal Cancer in the PLCO Cancer Screening Trial | Linglong Peng | The Second Affiliated Hospital of Chongqing Medical University | PLCO | Dec 23, 2022 | PLCO-1134 |
Computational Pathology in Ovarian Cancer | Sandra Orsulic | Regents University of California Los Angeles | PLCO | Dec 19, 2022 | PLCOI-1132 |
Associations of Dietary Factors with Risk of Chronic Disease and Mortality | Jiaqi Huang | The Second Xiangya Hospital of Central South University | PLCO | Dec 19, 2022 | PLCO-1131 |
Indirect comparisons of screening strategies and generalizing effects to a nationally representative population by combining trial data | Issa Dahabreh | President and Fellows of Harvard College on behalf of Harvard T.H. Chan School of Public Health | PLCO | Dec 19, 2022 | PLCO-1130 |
Meta-data for CRDC pilot study | Eric Miller | National Cancer Institute | PLCO | Dec 9, 2022 | PLCO-1128 |
AI-driven Automatic Chest X-Ray Cardiovascular structure quantification for Cardiovascular Risk Estimation | Richard Du | Detect Medical Technology Limited | PLCO | Dec 8, 2022 | PLCOI-1122 |
Early Warning of Ovarian Cancer | Michael Korenberg | Queen's University | PLCO | Dec 8, 2022 | PLCO-1126 |
Association between positive cancer screening and death from cardiovascular disease | yubei huang | Tianjin Medical University Cancer Institute and Hospital | PLCO | Dec 8, 2022 | PLCO-1125 |
Early detection of ovarian cancer via biomarkers using Machine Learning techniques | Kritika Murali | MIT Art Design and Technology University | PLCO | Dec 8, 2022 | PLCO-1124 |
A further look into the PLCO data with open questions on PSA, active surveillance, and risk factors in prostate cancer | Yulong Gu | Stockton University | PLCO | Dec 5, 2022 | PLCO-1118 |